Compounds > beta-n-methylamino-l-alanine
Page last updated: 2024-08-26

beta-n-methylamino-l-alanine and Central Nervous System Diseases

beta-n-methylamino-l-alanine has been researched along with Central Nervous System Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Downing, TG; Scott, LL; van Onselen, R1
Barceloux, DG1

Reviews

1 review(s) available for beta-n-methylamino-l-alanine and Central Nervous System Diseases

ArticleYear
Cycad seeds and chronic neurologic disease (Cycas species).
    Disease-a-month : DM, 2009, Volume: 55, Issue:6

    Topics: Alzheimer Disease; Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Animals; Central Nervous System Diseases; Chronic Disease; Cyanobacteria Toxins; Cycas; Foodborne Diseases; Humans; Neurotoxins; Parkinson Disease; Plant Poisoning; Seeds

2009

Other Studies

1 other study(ies) available for beta-n-methylamino-l-alanine and Central Nervous System Diseases

ArticleYear
Evaluating amino acids as protectants against β-N-methylamino-l-alanine-induced developmental neurotoxicity in a rat model.
    Toxicology and applied pharmacology, 2020, 09-15, Volume: 403

    Topics: Amino Acids; Amino Acids, Diamino; Animals; Behavior, Animal; Central Nervous System Diseases; Cyanobacteria Toxins; Female; Maze Learning; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley

2020